[128] In contrast, other DAT inhibitors such as bupropion have not been noticed to show this effect.[129] These observations have prompted the hypothesis that methylphenidate may well work as a "DAT inverse agonist" or "destructive allosteric modifier of the DAT" by reversing the direction with the dopamine efflux because of the DAT at increased do